Treatment of Recurrent Hepatitis C after Liver Transplantation
- Details
- Category: Liver Transplant - HCV
- Published on Friday, 25 February 2011 03:47
- Written by Liz Highleyman
Hepatitis C patients with advanced liver disease may benefit from interferon-based therapy before receiving a liver transplant, but side effects are common and response rates are low, according to a systematic research review described in the January 2011 issue of Alimentary Pharmacology and Therapeutics. Injected antibodies do not prevent the new liver from becoming infected, but pegyalted interferon plus ribavirin can cures recurring HCV about 30% of the time.
More Articles...
- HIV Coinfection Does Not Worsen Liver Transplant Outcomes in People with Hepatitis B or C
- Does CD4 Cell Count Influence Liver Fibrosis in HIV/HCV Coinfected People?
- Screening for Liver Cancer in HIV/HCV Coinfected People
- Rifaximin Reduces Encephalopathy Recurrence, Improves Quality of Life in People with Liver Cirrhosis
- EASL 2010: HIV/HCV Coinfected Patients with Acute Hepatitis C Are Equally Likely to Achieve Sustained Response with Interferon plus Ribavirin
Web Design and Development by